Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
2.
Rev. esp. cardiol. (Ed. impr.) ; 76(11): 845-851, Nov. 2023. tab, graf
Article in Spanish | IBECS | ID: ibc-226968

ABSTRACT

Introducción y objetivos: La insuficiencia tricuspídea (IT) significativa se asocia con un aumento de la morbimortalidad. La valoración clínica del paciente con IT es un reto. Nuestro objetivo es establecer una nueva clasificación clínica, específica para pacientes con IT, denominada clasificación 4A, y evaluar su impacto pronóstico. Métodos: Se incluyó a pacientes evaluados en la clínica valvular, con IT aislada al menos grave y ausencia de antecedentes de insuficiencia cardiaca (IC). Se recogieron síntomas y signos de astenia, edema en extremidades inferiores, dolor o distensión abdominal y anorexia (asthenia, ankle swelling, abdominal pain or distention and anorexia) y se realizó un seguimiento cada 6 meses. La clasificación 4A abarca desde A0 (ninguna A) a A3 (3 o 4 Aes). Se definió un resultado combinado de ingreso hospitalario debido a IC derecha o muerte de causa cardiovascular. Resultados: Se incluyó a 135 pacientes con IT significativa entre 2016 y 2021 (el 69% mujeres; media de edad, 78±7 años). Durante un seguimiento medio de 26 [intervalo intercuartílico, 10-41] meses, 53 pacientes (39%) alcanzaron el resultado combinado. Ingresaron por IC 46 (34%) y murió un 5% (n=7). Al inicio, el 94% de los pacientes se encontraban en NYHA I o II, mientras que el 24% ya presentaba A2 o A3. La presencia de A2 o A3 se asoció con una alta incidencia de eventos. El cambio en la puntuación de la clasificación 4A fue un marcador independiente de IC y muerte cardiovascular (HR ajustada por unidad de cambio de la clasificación 4A=1,95 [1,37-2,77]; p <0,001). Conclusiones: Se muestra una nueva clasificación clínica específica para pacientes con IT basada en signos y síntomas de IC derecha y predictora de eventos.


Introduction and objectives: Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. Clinical evaluation of TR patients is challenging. Our aim was to establish a new clinical classification specific for patients with TR, the 4A classification, and evaluate its prognostic performance. Methods: We included patients with isolated TR that was at least severe and without previous episodes of heart failure (HF) who were assessed in the heart valve clinic. We registered signs and symptoms of asthenia, ankle swelling, abdominal pain or distention and/or anorexia and followed up the patients every 6 months. The 4A classification ranged from A0 (no A) to A3 (3 or 4 As present). We defined a combined endpoint consisting of hospital admission due to right HF or cardiovascular mortality. Results: We included 135 patients with significant TR between 2016 and 2021 (69% females, mean age 78±7 years). During a median follow-up of 26 [IQR, 10-41] months, 39% (n=53) patients had the combined endpoint: 34% (n=46) were admitted for HF and 5% (n=7) died. At baseline, 94% of the patients were in NYHA I or II, while 24% were in classes A2 or A3. The presence of A2 or A3 conferred a high incidence of events. The change in 4A class remained an independent marker of HF and cardiovascular mortality (adjusted HR per unit of change of 4A class, 1.95 [1.37-2.77]; P<.001). Conclusions: This study reports a novel clinical classification specifically for patients with TR that is based on signs and symptoms of right HF and has prognostic value for events.(AU)


Subject(s)
Humans , Male , Female , Tricuspid Valve Insufficiency/classification , Heart Failure , Asthenia , Edema , Abdominal Pain , Anorexia , Indicators of Morbidity and Mortality , Cardiology , Heart Diseases , Heart Diseases/complications
3.
Circ Cardiovasc Imaging ; 14(2): e011805, 2021 02.
Article in English | MEDLINE | ID: mdl-33517670

ABSTRACT

BACKGROUND: A new grading of tricuspid regurgitation (TR) beyond severe has been proposed. However, few studies assessing the validity of such a new grading scheme of TR have been conducted. Therefore, we evaluated associations of TR grades beyond severe with patient outcome and hemodynamics. METHODS: We retrospectively studied patients who underwent 2-dimensional echocardiography and were diagnosed with severe TR between January 2014 and December 2015. According to the vena contracta width of TR (VC), the patients were classified into 2 groups: VC under 14 mm (VC<14 mm) and VC 14 mm or greater (VC≥14 mm). Hemodynamic parameters were estimated by echocardiography and were obtained by right heart catheterization. Cardiovascular events were defined as cardiovascular death or admission for heart failure. RESULTS: A total of 679 patients (mean 72±17 years, 56% women) were included. During follow-up (median, 158 days; range, 29-891), 210 patients experienced cardiovascular events. By multivariate analysis, VC≥14 mm and left ventricular ejection fraction were independent predictors of cardiovascular events (hazard ratio, 1.57 [1.06-2.33]; hazard ratio, 0.99 [0.98-0.99], respectively). Patients with VC≥14 mm had significantly lower cardiac index (median, 1.8 versus 2.1 L/min per m2, P=0.001) and a higher prevalence of right atrial pressure 15 mm Hg (74% versus 60%, P<0.001) on echocardiography. Also, right heart catheterization confirmed higher right atrial pressure in patients with VC≥14 mm than those with VC<14 mm (16±8 versus 12±6 mm Hg, P=0.004). The new subset classification developed by cardiac index and right atrial pressure both on echocardiography predicted cardiovascular events (Log-rank P<0.001). CONCLUSIONS: The relationship of VC≥14 mm to adverse outcome and poor hemodynamics showed the clinical relevance and need of a new grading system beyond severe. The new hemodynamic subset classification provides additional prognostic value for cardiovascular events in patients with severe TR.


Subject(s)
Echocardiography/methods , Stroke Volume/physiology , Tricuspid Valve Insufficiency/diagnosis , Tricuspid Valve/diagnostic imaging , Ventricular Function, Left/physiology , Aged , Female , Follow-Up Studies , Humans , Male , Prognosis , Retrospective Studies , Severity of Illness Index , Time Factors , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/physiopathology
5.
Am J Cardiol ; 132: 119-125, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32741538

ABSTRACT

It is well known that some patients present with "more than severe" tricuspid regurgitation (TR). We aimed to assess the prognosis of these very severe TR patients. We defined very severe TR using 3 simple echocardiographic parameters: a coaptation gap≥10mm, a laminar TR flow and a systolic reversal of the hepatic vein flow. We included 259 consecutive patients (76 ± 13 years; 46% men) with moderate-to-severe TR (n = 114) and severe TR (n = 145). The primary end point was the combination of hospitalisation for right heart failure (RHF) and cardiovascular mortality. Median follow-up was 24(7 to 47) months. In patients with severe TR, 52 (36%) met the definition of very severe TR. These patients were younger, had more history of RHF and were more frequently treated with loop diuretics than those with moderate-to-severe TR (all p < 0.001). Four-year event-free survival rates were 68 ± 5%, for moderate-to-severe TR, 48 ± 6% for severe TR and only 35 ± 7% for very-severe TR (p < 0.001). On multivariable analysis, after adjustment for outcome predictors including age, comorbidity, RHF, TR etiology, left and right ventricular dysfunction, and tricuspid valve surgery, patients with very severe TR had a worsened prognosis than those with moderate-to-severe TR (Adjusted Hazard Ratio [95% Confidence Interval] = 2.43 [1.18 to 5.53]; p = 0.002) and than those with severe TR (Adjusted Hazard Ratio [95% Confidence Interval] = 2.23 [1.06 to 5.56]; p = 0.015). In conclusion, very severe TR is frequent in patients with severe TR, corresponds to a more advanced stage of the disease and is associated with poor outcomes. Therefore, the use of a 5-grade classification of TR severity is justified in routine clinical practice. (ID-RCB: 2017-A03233-50).


Subject(s)
Echocardiography, Doppler/methods , Tricuspid Valve Insufficiency/classification , Tricuspid Valve/diagnostic imaging , Aged , Disease-Free Survival , Female , Humans , Male , Retrospective Studies , Severity of Illness Index , Tricuspid Valve Insufficiency/diagnosis
6.
Eur Heart J Cardiovasc Imaging ; 20(9): 1035-1042, 2019 Sep 01.
Article in English | MEDLINE | ID: mdl-30830219

ABSTRACT

AIMS: Patients with significant tricuspid regurgitation (TR) addressed according the new classification in torrential TR may have different prognosis compared with just severe TR patients. We sought to determine distribution and mechanism of consecutive severe TR patients, in accordance with aetiology and severity by applying the new proposed classification scheme and their long-term outcomes. METHODS AND RESULTS: Between January and December 2013, 249 patients with significant TR referred to the cardiac imaging unit (mean age 79.9 ± 10.2 years; 29.8% female) were included. Patients were divided according to aetiology in six groups, and TR severity was reclassified into severe, massive, and torrential TR. The follow-up period was of 313 ± 103 days. When considering cardiovascular mortality, patients in the massive/torrential group showed the highest number of events (P < 0.007). Patients with TR due to pulmonary diseases had the worst prognosis according to different aetiology. Noteworthy, the best predictors for the combined endpoint [cardiovascular mortality and readmission admission for heart failure (HF)] were TR severity according to the new classification [hazard ratio (HR) 2.48, 95% confidence interval (CI) 1.25-4.93] and clinical scores such as New York Heart Association classification and congestive status (HR 1.78, 95% CI 1.28-2.49; HR 2.08, 95% CI 1.06-4.06, respectively). CONCLUSION: Patients with massive/torrential TR and patients with comorbidities, especially pulmonary disease, were identified as populations at higher risk of death and readmission for HF. New classification scheme and clinical assessment may establish who may benefit the most of intensive therapeutic treatments and intervention on the tricuspid valve.


Subject(s)
Echocardiography/methods , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve Insufficiency/physiopathology , Aged, 80 and over , Female , Humans , Male , Prognosis , Retrospective Studies , Severity of Illness Index , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/etiology
7.
Can J Cardiol ; 35(4): 389-395, 2019 04.
Article in English | MEDLINE | ID: mdl-30852048

ABSTRACT

BACKGROUND: Tricuspid regurgitation (TR) has been associated with cardiac rhythm device (CRD) implantation with intracardiac lead insertion. However, data on the incidence of postdevice TR are limited and largely from retrospective studies. We hypothesized that permanent lead implantation would be associated with an increase in TR. METHODS: We prospectively included consecutive patients with a clinical indication for CRD. Patients underwent transthoracic echocardiography 1 month before and 1 year after CRD implantation. RESULTS: A total of 328 patients were prospectively enrolled (69 ± 15 years, 38% female). Echocardiograms before and 1 year after CRD were available in 290 patients (15 died, 23 lost to follow-up). Compared with baseline, there was a significant change in TR grade 1 year after CRD insertion (no/trivial TR: 66% vs 29%; mild TR: 29% vs 61%; moderate TR: 3% vs 8%; severe TR 2% vs 2%; P < 0.001 for an increase in TR by at least 1 grade). Compared with baseline, there was a higher prevalence of moderate or severe TR in the 247 patients with CRD without cardiac resynchronization therapy (4% vs 10%, P = 0.004), but no progression in the 43 patients who received cardiac resynchronization therapy (14% vs 11%, P = 1). Multivariable analysis in the patients with less than moderate TR at baseline (n = 274) showed that only a history of atrial fibrillation was independently associated with progression to moderate or severe TR after correction for baseline TR grade (P = 0.013). CONCLUSIONS: One year after endocardial lead insertion, there was a 5% increase in the prevalence of moderate or severe TR, which may be clinically relevant.


Subject(s)
Cardiac Resynchronization Therapy , Defibrillators, Implantable , Pacemaker, Artificial , Tricuspid Valve Insufficiency/epidemiology , Aged , Canada/epidemiology , Disease Progression , Echocardiography , Female , Heart Atria/diagnostic imaging , Humans , Male , Multivariate Analysis , Prevalence , Prospective Studies , Severity of Illness Index , Stroke Volume , Tricuspid Valve Insufficiency/classification
9.
Hosp Pract (1995) ; 45(5): 209-214, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28952403

ABSTRACT

OBJECTIVES: Tricuspid regurgitation (TR) is common in patients referred for cardiac assessment. Nonetheless, current estimates of its prevalence and contributing factors are limited. The aim of the present study was to evaluate the prevalence and demographics of TR in patients referred for echocardiography assessment at two University-affiliated hospitals. METHODS: A total of 6711 consecutive Chinese patients were recruited as part of the Chinese Valvular Heart Disease Study (CVATS). RESULTS: The most common valvular lesion was TR (54.7%), followed by mitral regurgitation (44.7%) and aortic regurgitation (26.5%). Clinically significant (moderate or severe) TR was identified in 8.4% with the proportion increased from 3.9% amongst those aged <51 to 15.9% in those aged ≥81. Multivariable adjustment demonstrated that significant TR was associated with age, congenital heart disease, chronic obstructive pulmonary disease, left-sided valvular heart disease (VHD), impaired left ventricular ejection fraction <50%, atrial fibrillation and pulmonary hypertension. CONCLUSIONS: Among all types of VHD, TR was the most common and was identified in over half of the subjects and clinically significant in 8.4%. These unique data provide contemporary clinical and epidemiological characteristics of TR in a large cohort of patients referred for cardiac assessment and confirm the increased burden of TR in the aged population.


Subject(s)
Tricuspid Valve Insufficiency/epidemiology , Age Factors , Aged , Aged, 80 and over , Cardiovascular Diseases/epidemiology , China/epidemiology , Comorbidity , Diabetes Mellitus/epidemiology , Female , Humans , Hyperlipidemias/epidemiology , Hypertension, Pulmonary/epidemiology , Male , Middle Aged , Prevalence , Pulmonary Disease, Chronic Obstructive/epidemiology , Risk Factors , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/diagnostic imaging
10.
Herz ; 42(7): 644-650, 2017 Nov.
Article in German | MEDLINE | ID: mdl-28791435

ABSTRACT

Tricuspid valve regurgitation is frequently found as a result of right ventricular remodeling due to advanced left heart diseases. Drug treatment is limited to diuretics and the cardiac or pulmonary comorbidities. Due to the high risk only a small percentage of patients are amenable to surgical treatment of tricuspid regurgitation in those who undergo left-sided surgery for other reasons. Catheter-based procedures are an attractive treatment alternative, particularly since the strong prognostic impact of tricuspid regurgitation suggests an unmet need of treatment, independent of the underlying heart disease. A vast amount of clinical experience exists for the MitraClip system for treatment of mitral regurgitation. A first case series shows that the application for treatment of tricuspid regurgitation is technically feasible, seems to be safe and the degree of valve regurgitation can be reduced. In this review the background of tricuspid regurgitation treatment is summarized and first experiences and perspectives with the MitraClip system are assessed.


Subject(s)
Cardiac Catheterization/instrumentation , Cardiac Valve Annuloplasty/instrumentation , Surgical Instruments , Tricuspid Valve Insufficiency/surgery , Equipment Design , Feasibility Studies , Humans , Prognosis , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/diagnosis
11.
Herz ; 42(7): 629-633, 2017 Nov.
Article in German | MEDLINE | ID: mdl-28835985

ABSTRACT

Pathologies of the right heart and the tricuspid valve were not recognized to be of prognostic relevance for many years. Available evidence showing the progressive nature of right heart diseases with direct impact on patient survival have changed current understanding of its clinical importance. Visualization and a profound understanding of the right heart anatomy are prerequisites for the development of modern and still experimental treatment strategies. Transthoracic and transesophageal echocardiography enable a standardized and clear visualization and assessment of the right heart anatomy and its pathological changes.


Subject(s)
Echocardiography, Three-Dimensional , Echocardiography, Transesophageal , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve/diagnostic imaging , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Papillary Muscles/diagnostic imaging , Papillary Muscles/physiopathology , Prognosis , Reference Values , Tricuspid Valve/physiopathology , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/physiopathology , Tricuspid Valve Insufficiency/therapy
12.
Cardiol Young ; 21(2): 121-9, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21205419

ABSTRACT

BACKGROUND AND AIM: Congenital tricuspid regurgitation is an extremely rare condition. The morphologic heterogeneity makes it difficult to derive any conclusions regarding the best strategy for management of this condition. METHODS: We analysed the published literature on "congenital tricuspid regurgitation" using MEDLINE. In addition, the reference sections of all relevant articles were searched to identify additional cases. Studies published till June 2009 are included. RESULTS: As far as we could establish, there were 123 cases of congenital tricuspid regurgitation. Of these, 63 were documented during surgery, 38 during autopsy, and 22 were diagnosed by echocardiography or cardiac catheterisation. The mean age was 22.57 years, with a standard deviation of 23.42 years, and the age ranged from 1 day to 80 years, with a median of 16 years. There was a male predominance, with a male-to-female ratio of approximately 3:2. CONCLUSION: Congenital tricuspid regurgitation is an uncommon clinical entity with wide anatomical variations. The severity of disease dictates the presentation in infancy, childhood, or adulthood. Tricuspid valve repair is the ideal treatment whenever feasible, especially in children. We propose a new classification for congenital tricuspid regurgitation, which not only includes the anatomical variations, but can also help the surgeon in deciding on the best strategy for management.


Subject(s)
Tricuspid Valve Insufficiency , Tricuspid Valve/abnormalities , Humans , Prevalence , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/congenital , Tricuspid Valve Insufficiency/epidemiology , United States/epidemiology
14.
Am J Cardiol ; 92(5): 643-5, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-12943899

ABSTRACT

In a cohort of 56 school-aged children with repaired tetralogy of Fallot, significant (moderate to severe) tricuspid regurgitation was common (32% of patients) and was related to both tricuspid annulus dilatation and structural valve abnormalities that were potentially related to previous surgery. Even after adjusting for pulmonary regurgitation, tricuspid regurgitation was significantly correlated with right ventricular volume (r= 0.39, p = 0.009), suggesting that tricuspid regurgitation as well as pulmonary regurgitation may contribute significantly to progressive right ventricular dilatation in this population.


Subject(s)
Hypertrophy, Right Ventricular/etiology , Postoperative Complications/etiology , Pulmonary Valve Insufficiency/etiology , Tetralogy of Fallot/complications , Tetralogy of Fallot/surgery , Tricuspid Valve Insufficiency/etiology , Cardiac Volume , Child , Child, Preschool , Disease Progression , Echocardiography, Doppler, Color , Follow-Up Studies , Humans , Hypertrophy, Right Ventricular/diagnosis , Hypertrophy, Right Ventricular/physiopathology , Infant , Magnetic Resonance Imaging , Postoperative Complications/diagnosis , Postoperative Complications/physiopathology , Prevalence , Pulmonary Valve Insufficiency/diagnosis , Pulmonary Valve Insufficiency/physiopathology , Risk Factors , Severity of Illness Index , Stroke Volume , Systole , Time Factors , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/diagnosis , Tricuspid Valve Insufficiency/epidemiology , Tricuspid Valve Insufficiency/physiopathology
16.
Eur J Cardiothorac Surg ; 18(5): 565-9, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11053818

ABSTRACT

OBJECTIVE: The choice of the valve substitute in the tricuspid position remains controversial. A St. Jude Medical valve is a choice of valve substitute and its lower thrombogenicity and excellent hemodynamic performance have been reported even in the tricuspid position. However, little is known of the long-term durability of the St. Jude Medical valve in the tricuspid position. Our long-term experience of tricuspid valve replacement showed the higher thrombogenicity than we had expected, therefore, this study was done to reconsider our strategy for valve choice. METHODS: This study reviewed 23 patient who underwent 25 tricuspid valve replacements with the St. Jude Medical valves from 1980 to 1997. The mean age was 40 years. Eleven patients (48%) were men. There were four in-hospital deaths (17%). The remaining 19 patients were all alive and followed from 2.2 to 19.0 years (mean 11.8 years). RESULTS: The overall survival, including hospital mortality, was 83%, 10 and 15 years after surgery. Valve thrombosis occurred in six patients. Freedom from valve thrombosis was 78 and 70%, 10 and 15 years after surgery, respectively. The linearized rate of the valve thrombosis was 2.9%/patient-years. Six patients required reoperation. The mean interval to reoperation was 9.5 years. Freedom from reoperation was 83% and 75%, 10 and 15 years after surgery, respectively. The linearized rate of the reoperation was 2.8%/patient-years. No structural valve deterioration was found. Echocardiographic study showed that the function of the St. Jude Medical valve without valve-related complications was well maintained. CONCLUSIONS: The higher thrombogenicity of the St. Jude Medical valve in the tricuspid position altered our choice of valve substitutes from the St. Jude Medical valve to a bioprosthesis which is lack of need for anticoagulant therapy except for juvenile patients who are able to maintain potent anticoagulant therapy.


Subject(s)
Heart Valve Prosthesis Implantation/adverse effects , Heart Valve Prosthesis Implantation/instrumentation , Tricuspid Valve Insufficiency/surgery , Tricuspid Valve Stenosis/surgery , Adolescent , Adult , Aged , Child , Child, Preschool , Echocardiography , Female , Follow-Up Studies , Heart Diseases/etiology , Heart Valve Prosthesis Implantation/mortality , Hemodynamics , Hospital Mortality , Humans , Linear Models , Male , Middle Aged , Reoperation , Survival Analysis , Thrombosis/etiology , Treatment Outcome , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/diagnosis , Tricuspid Valve Insufficiency/mortality , Tricuspid Valve Insufficiency/physiopathology , Tricuspid Valve Stenosis/classification , Tricuspid Valve Stenosis/diagnosis , Tricuspid Valve Stenosis/mortality , Tricuspid Valve Stenosis/physiopathology
20.
Wien Klin Wochenschr ; 107(6): 184-7, 1995.
Article in German | MEDLINE | ID: mdl-7732691

ABSTRACT

The extent of right heart strain determines the prognosis of chronic lung disease. The value of a simple semiquantitative echocardiographic grading system for cor pulmonale was assessed in 69 patients (24 females, 45 males, age 61 +/- 12 years, ranging from 28-82 years) suffering from chronic lung disease. The patients were classified by echocardiography into four groups, Grade 0 consisting of those without evidence of right heart strain and three groups showing increasing severity of change (Grade I: right ventricular hypertrophy; Grade II: I + right ventricular dilation; Grade III: II + Dilation of the inferior vena cava). Echocardiographic investigation, at least from the subcostal view, and grading was possible in all patients. A correlation was found between the echocardiographic grading and the mean pulmonary artery pressure (PAP)-normal echo study 15.7 +/- 4.8; grade I 21.1 +/- 5.6; grade II 28.8 +/- 10.2; grade III 39.4 +/- 9.4 mmHg. In addition, patients with stress-induced pulmonary hypertension (PHT) were detected by Doppler echocardiography. 6 of 11 patients with latent PHT already showed evidence of cor pulmonale (4 Grade I and 2 Grade II). In 42 patients (61%) the systolic PAP was estimated by measuring the velocity of the tricuspid insufficiency jet with Doppler, and these data correlated closely with the invasive data (p < 0.001; r = 0.81). Doppler echocardiography for evaluation of cor pulmonale is feasible even in patients with chronic lung disease and limited acoustic windows. Semiquantitative grading correlates well with invasive data. Here, this technique is useful as a baseline study as well as for the follow-up of patients with chronic lung disease.


Subject(s)
Echocardiography , Lung Diseases, Obstructive/diagnostic imaging , Pulmonary Heart Disease/diagnostic imaging , Adult , Aged , Aged, 80 and over , Blood Flow Velocity/physiology , Echocardiography, Doppler , Exercise Test , Female , Hemodynamics/physiology , Humans , Hypertension, Pulmonary/classification , Hypertension, Pulmonary/diagnostic imaging , Hypertrophy, Right Ventricular/classification , Hypertrophy, Right Ventricular/diagnostic imaging , Lung Diseases, Obstructive/classification , Male , Middle Aged , Pulmonary Heart Disease/classification , Tricuspid Valve Insufficiency/classification , Tricuspid Valve Insufficiency/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...